Frickmann Hagen, Loderstädt Ulrike, Nickel Beatrice, Poppert Sven, Odermatt Peter, Sayasone Somphou, Van Esbroeck Marjan, Micalessi Isabel, Cnops Lieselotte, Adisakwattana Poom, Leboulle Gérard, Landt Olfert, Thye Thorsten, Tannich Egbert
Department of Microbiology and Hospital Hygiene, Bundeswehr Hospital Hamburg, 20359 Hamburg, Germany.
Department of Medical Microbiology, Virology and Hygiene, University Medicine Rostock, 18057 Rostock, Germany.
Pathogens. 2021 Aug 22;10(8):1067. doi: 10.3390/pathogens10081067.
While hybridization probe-based real-time PCR assays targeting highly repetitive multi-copy genome sequences for the diagnosis of complex or complex from human serum are well established, reports on the evaluation of respective assays for the identification of complex DNA in human serum are scarce. Here, we assessed the potential use of the retrotransposon sequences and from , and for the diagnosis of Asian infections. Based on available sequences and newly provided and sequences, hybridization probe-based real-time PCRs targeting and of the complex were designed both as consensus primer assays as well as multi-primer assays for the coverage of multiple variants of the target sequences. The assays were established using plasmids and DNA. While the consensus primer assays failed to detect DNA in human serum samples, the multi-primer assays showed positive or borderline positive results but only in 9.8% (6/61) of serum samples from patients with confirmed infections. Some cross-reactions with samples positive for or were observed but with the -PCR only. In spite of the low sensitivity, the presented experience may guide future evaluations of complex-specific PCRs from human serum.
虽然基于杂交探针的实时PCR检测方法,针对高度重复的多拷贝基因组序列用于诊断人血清中的复杂或[具体复杂物]已得到充分确立,但关于评估各自检测方法以鉴定人血清中复杂DNA的报告却很少。在此,我们评估了来自[具体来源1]、[具体来源2]、[具体来源3]和[具体来源4]的逆转录转座子序列[具体序列1]和[具体序列2]用于诊断亚洲[具体感染类型]感染的潜在用途。基于可用的[具体序列类型1]序列以及新提供的[具体序列类型2]和[具体序列类型3]序列,针对[具体复杂物]的[具体序列1]和[具体序列2]设计了基于杂交探针的实时PCR,既作为共识引物检测方法,也作为多引物检测方法以覆盖目标序列的多个变体。这些检测方法使用质粒和[具体DNA类型]DNA建立。虽然共识引物检测方法未能检测出人血清样本中的[具体DNA类型]DNA,但多引物检测方法显示出阳性或临界阳性结果,但仅在确诊[具体感染类型]感染患者的9.8%(6/61)血清样本中出现。观察到与[具体阳性样本类型1]或[具体阳性样本类型2]阳性样本存在一些交叉反应,但仅在[具体PCR类型]中出现。尽管灵敏度较低,但所呈现的经验可能会指导未来对人血清中复杂特异性PCR的评估。